The QualityStocks Daily Stock List
- CleanSpark, Inc. (CLSK)
- Cuentas, Inc. (CUEN)
- FLYHT Aerospace Solutions Ltd. (FLYLF)
- International Land Alliance, Inc. (ILAL)
- LandStar, Inc. (LDSR)
- Orezone Gold Corporation (ORZCF)
- Resolute Mining Limited (RMGGF)
- Wize Pharma, Inc. (WIZP)
- Astea International, Inc. (ATEA)
- Esports Entertainment Group, Inc. (GMBL)
- Maricann Group, Inc. (MRRCF)
- Goldsource Mines, Inc. (GXSFF)
- Tempus Applied Solutions Holdings, Inc. (TMPS)
- Provision Holding, Inc. (PVHO)
CleanSpark, Inc. (CLSK)
Uptick Newswire, PR Newswire, Market Screener, Stockhouse, Simply Wall St, YCharts, Insider Financial, Micro Cap Daily, Financial Buzz, MarketWatch, MarketBeat, Equities, GlobeNewswire, Pot Stock News, Insider Tracking, Wallet Investor, Stockwatch, Barchart, Trading View, InvestorsHub, and Dividend Investor reported earlier on CleanSpark, Inc. (CLSK), and today we report on the Company, here at the QualityStocks Daily Newsletter.
CleanSpark, Inc. is a microgrid company with advanced engineering, software and controls for innovative distributed energy resource (DER) and microgrid deployments. It provides advanced energy software and control technology that enables a plug-and-play enterprise solution to modern energy challenges. The Company's customers include energy consumers and the distributed energy ecosystem at large: developers, installers, EPCs, IPPs, and energy storage vendors. The OTCQB-listed Company was formerly known as Stratean, Inc. It changed its name to CleanSpark, Inc. in November 2016. CleanSpark is headquartered in Utah.
CleanSpark’s services consist of intelligent energy monitoring and controls, microgrid design and engineering, microgrid consulting services, and turn-key microgrid implementation services. The Company’s software enables energy users to obtain resiliency and economic optimization. Its software is uniquely capable of enabling a microgrid to be scaled to the user's specific needs. It can be broadly implemented across commercial, industrial, military, agricultural, and municipal deployment.
CleanSpark’s Microgrid Value Stream Optimizer outputs are a client’s customized guide to maximizing their energy project’s ROI (Return on Investment). State-of-the-art data analytics account for real costs, precise utility rate models, equipment performance, and actual energy consumption. They outline what type of energy resources are to be built, what it will cost, and how it will perform upon deployment.
CleanSpark also has its mPulse software. Its mPulse software is an innovation in controls capable of integrating manifold Distributed Energy Resources (DER). This includes storage, renewables and fossil fuel technologies.
The Company’s intelligent software package collects, archives, as well as analyzes data 24/7 providing real-time control and reporting. Concerning Engineering & Grid Development Services, CleanSpark’s mVSO provides critical information. It is also the starting point for the Company’s microgrid development services.
In September, CleanSpark announced it was selected to conduct a project feasibility study for the creation of an independent and comprehensive power system for a cannabis grower to be located in a rural part of California. With this agreement, CleanSpark will produce a project feasibility analysis for the first phase of the customer's project.
The analysis will include the appropriate energy storage, solar PV system sizes, projected utility savings, capital costs, operations and maintenance costs. The analysis will also include a 20-year economic financial model depicting the projects return on investment (ROI), cash flows and tax effects. The expectation is that the final recommendation will include detailed specifications and implementation plans for a comprehensive solution with energy sources, storage and software controls sized to optimize performance.
CleanSpark, Inc. (CLSK), closed Tuesday's trading session at $0.75, off by 1.3158%, on 93,443 volume with 45 trades. The average volume for the last 3 months is 72,886 and the stock's 52-week low/high is $0.699999988/$7.9499998.
Cuentas, Inc. (CUEN)
TeleTrader, Market Screener, Wallet Investor, PR Newswire, Investing.com, Stockhouse, Simply Wall St, InvestorsHub, GlobeNewswire, and Nasdaq reported previously on Cuentas, Inc. (CUEN), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Cuentas, Inc. is a top FinTech (Financial Technology) provider of mobile banking and payment solutions serving Latino and Hispanic consumers. The Company uses technical innovation together with existing and emerging technologies to deliver accessible, efficient, and reliable mobile, new-era and traditional financial services to consumers. Cuentas has its proprietary Cuentas General Purpose Reloadable (GPR) Card. The Company has its corporate office in Miami, Florida. Cuentas lists on the OTC Markets Group’s OTCQB.
Cuentas utilizes technology to bridge the gap between traditional financial services and the underbanked U.S. Latino population. The Company’s services include, but are not limited to, mobile banking, online banking, prepaid debit, bill pay, ACH and mobile deposits, cash remittance, peer to peer money transfer, and bank accounts to customers who previously could not get bank accounts.
The Cuentas General Purpose Reloadable (GPR) Card provides holders with digital wallets, discounts for purchases at major physical and online retailers, free telecom, and the ability to purchase digital content. The card will be available in over 31,000 bodegas.
The Cuentas Fintech Card is an online bank account integrated with the Cuentas branded general purpose reloadable card (GPR). It provides a total online banking solution to all, including those without a U.S. government issued ID. Pertaining to Mobile Wallet, the in-app Mobile Wallet offers FinTech Card functionality for online and mobile purchases. The Cuentas Virtual Marketplace provides discounted gift cards to Cuentas cardholders. These can be stored in the Cuentas Mobile Wallet and be used online, sent electronically to friends or family, and redeemed for a physical gift card.
Recently, Cuentas announced that it entered into a processing services agreement with InComm, a foremost payments technology company. With the terms of this 5-year agreement, InComm will act as a processor for the Cuentas prepaid debit card.
In addition, Cuentas recently announced that it appointed Mr. Sylwin Grinman as Chief Operating Officer. Mr. Grinman brings more than 40 years of international leadership experience to Cuentas. Formerly, he served as International General Manager at Hoffman Laroche Biomedical in Switzerland. Before Hoffman Laroche Biomedical, he was President of Shiseido Japan Group, a top cosmetics and pharmaceuticals firm, leading their operations across the European Union. Mr. Grinman holds an Engineering Degree in Bio-Medical Technology and Treatments from Université Paris-Dauphine and École Centrale de Paris.
Cuentas, Inc. (CUEN), closed Tuesday's trading session at $2.35, even for the day, on 1 volume with 1 trade. The average volume for the last 3 months is 2,962 and the stock's 52-week low/high is $0.535000026/$5.75.
FLYHT Aerospace Solutions Ltd. (FLYLF)
TipRanks, Wallmine, Stockwatch, Wallet Investor, Stockhouse, Invest Tribune, GuruFocus, Morningstar, Seeking Alpha, Dividend Investor, and Nasdaq reported beforehand on FLYHT Aerospace Solutions Ltd. (FLYLF), and today we are highlighting Company, here at the QualityStocks Daily Newsletter.
FLYHT Aerospace Solutions Ltd. provides real-time aircraft intelligence and cockpit communications for the aerospace industry. Its corporate mission is to improve aviation safety, efficiency and profitability. The Company provides its differentiated aircraft and enterprise-based solutions to deliver real-time, flight-deck, satellite connectivity for tracking, health monitoring, and streaming of operational, maintenance and weather data. Airlines, leasing companies, fractional owners and original equipment manufacturers (OEMs) install FLYHT Aerospace Solutions’ differentiated aircraft and enterprise-based solutions.
Established in 1998, FLYHT Aerospace Solutions is based in Calgary, Alberta. The Company also has an office in Littleton, Colorado. FLYHT lists on the OTC Markets Group’s OTCQX. The Company previously went by the name AeroMechanical Services Ltd. It changed its name to FLYHT Aerospace Solutions Ltd. in May of 2012.
In essence, FLYHT Aerospace Solutions is a leading provider of Iridium satellite communications, global flight tracking including live FDR streaming capabilities, and aircraft health monitoring solutions. The Company’s Automated Flight Information Reporting System (AFIRS™) is specifically designed to enhance operational control, improve dispatch reliability and safety, and reduce costs.
The Automated Flight Information Reporting System (AFIRS™) is an Iridium-based SATCOM device installed on the aircraft. It uses the Company’s proprietary software to acquire and transmit aircraft data to the ground in real time, where it is then processed and distributed to the customer using FLYHT’s ground server network called UpTime™.
FLYHT Aerospace Solutions has a global presence with sales and installation support in China, South East Asia, the United States and Europe. The Company was presented the Excellence in Avionics Safety Systems Innovation Award from Avionics Magazine, presented at the Global Connected Aircraft Summit in 2015. Additionally, FLYHT was recognized with an Alberta Export Award in the Advancing Technologies Category, November 2011.
Last week, FLYHT Aerospace Solutions announced preliminary Q3 2019 highlights and updates. It secured a total of US $1.0 million in new sales contracts and purchase orders, assuming it provides services over the full term of the contracts. The Company reported a sales order backlog of greater than $50 million. It also successfully completed the integration of Panasonic Weather Solutions (PWS) assets, known as the “OneFLYHT” Program, which were acquired in October of 2018.
Furthermore, FLYHT expanded a licensing agreement with L3Harris Technologies. This is to customize the Automated Flight Information Reporting System (AFIRS) 228S for use as the Satcom option on the Airbus A220 family of aircraft. Also, the Company received the Chinese Validation of its newest Federal Aviation Administration (FAA) Airbus A320 AFIRS Supplemental Type Certificate (VSTC) that includes all models of the A320 family, including the “New Engine Option” (NEO). Moreover, FLYHT received FAA validation of its Transport Canada Supplemental Type Certificate (STC) for the Bombardier Q400.
FLYHT Aerospace Solutions Ltd. (FLYLF), closed Tuesday's trading session at $1.0308, off by 2.266%, on 24,100 volume with 23 trades. The average volume for the last 3 months is 14,587 and the stock's 52-week low/high is $0.670000016/$1.46000003.
International Land Alliance, Inc. (ILAL)
TipRanks, InvestorsHub, Interactive Brokers, OTC Markets, Morningstar, Dividend Investor, StockNews, Stockwatch, GlobeNewswire, Simply Wall St, Nasdaq, Last10k, Investors Hangout, and Stockopedia reported earlier on International Land Alliance, Inc. (ILAL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
International Land Alliance, Inc. is a global land investment and development company listed on the OTCQB. Its emphasis is on acquiring attractive raw land primarily in Northern Baja California, often within driving distance from Southern California. The Company’s chief goal is to sell desirable properties, at competitive prices, with favorable financing options for individual purchases and/or bulk purchases suitable for all kinds of investors and buyers. International Land Alliance has its corporate headquarters in San Diego, California.
The Company offers the option of financing with a guaranteed acceptance on any purchase for every customer. Through removing the middleman, loans are approved directly by International Land Alliance. This provides easy and affordable financing terms. In addition, there are no prepayment penalties, credit or background checks, and very competitively low interest rates.
International Land Alliance’s inventory includes properties that are residential, commercial, recreational, waterfront, ranch, hotel, and marina. The Company, by way of its wholly owned subsidiary, International Land Alliance, S.A. de C.V, a Mexican corporation, is the owner of 123 residential lots and commercial lots consisting of a total of 20-acres, called Valle Divino, located in Ensenada, Baja California. Furthermore, it is the owner of 1,344 residential lots and commercial lots consisting of 497-acres, named Oasis Park Resort, located in San Felipe, Baja California.
The Oasis Park Resort and Valle Divino Resort projects will undergo development as a second home resort or retirement destination in a planned community setting. The Company’s Villas Del Enologo at Rancho Tecate is a 2.6 acre parcel within the prestigious Rancho Tecate. It is a planned 24 -2B/2B Vineyard Villas with private wine cellar.
International Land Alliance closed in March 2019 on the purchase of 80 acres, the Emerald Grove Estates, and an 8,000 square foot event facility, the Chateau at Emerald Grove, in the wine country in Southern California for $1.1 million. It entered into a 3-year lease with future plans of development.
In August, International Land Alliance announced that it signed a Letter of Intent (LOI) to acquire approximately one acre of land with the plans and permits for 36 condominiums within the Bajamar Ocean Front Golf Resort. The Bajamar Ocean Front Golf Resort is a master planned golf community. It is situated 45 minutes south of the San Diego-Tijuana Border along the scenic toll road to Ensenada. The new project is branded “Costa Bajamar Oasis”. This project is planned to include six separate 3-story buildings with one-bedroom and two-bedroom floor plans with prices ranging from $109,000 to $169,000.
International Land Alliance, Inc. (ILAL), closed Tuesday's trading session at $0.55, off by 1.7857%, on 17,800 volume with 15 trades. The average volume for the last 3 months is 17,179 and the stock's 52-week low/high is $0.270099997/$5.00.
LandStar, Inc. (LDSR)
Zacks, Silicon Investor, TipRanks, Stockhouse, Stockwatch, Street Insider, Simply Wall St, InvestorsHub, OTC Markets, Insider Financial, Last10k, and Morningstar reported earlier on LandStar, Inc. (LDSR), and today we report on the Company, here at the QualityStocks Daily Newsletter.
LandStar, Inc. is the parent company of Data443™ Risk Mitigation, Inc., a leading data security and privacy company. Through its wholly-owned subsidiary DATA443™ Risk Mitigation, LandStar enables secure data - across local devices, network, cloud, and databases - at rest and in-flight. The Company’s products and services are central to cyber data security, GDPR, compliance, and governance capabilities. LandStar has its corporate office in Raleigh, North Carolina.
The Company’s product family includes ArcMail, a top provider of simple, secure and cost-effective email and enterprise archiving and management solutions. Additionally, its products include ARALOC™, a market leading secure, cloud-based platform for the management, protection and distribution of digital content to the desktop and mobile devices that protects an organization’s confidential content and intellectual property (IP) assets from leakage - malicious or accidental - without impacting collaboration between all stakeholders.
Furthermore, Landstar’s products include the WordPress GDPR Framework with more than 20,000 active users. It enables organizations of all sizes to comply with the GDPR and other privacy frameworks. Products also include The Virtual Data Protection Officer program, which offers a turnkey and outsourced DPO capability for smaller organizations; and, Data443™ Privacy Manager, which enables the full lifecycle of Data Privacy Access Requests, Remediation, Monitoring and Reporting.
Landstar’s products also include ClassiDocs™, its award-winning data classification and governance technology that supports CCPA, LGPD and GDPR compliance; and ClassiDocs™ for Blockchain, which provides an active implementation for the Ripple XRP that protects blockchain transactions from inadvertent disclosure and data leaks.
In September, LandStar announced another major client win within its DataExpress™ NonStop (DXNS) Secure Managed File Transfer Service. The customer is a foremost international payments technology company that operates in more than 200 countries and territories globally. DataExpress™ NonStop (DXNS) enables customers to schedule, route, format and securely transfer business-critical data over public and private networks. This enables legacy systems to link with present technology trends, supporting mission-critical transmission needs.
Mr. Jason Remillard, Chief Executive Officer of LandStar and Founder of Data443 said, “We are thrilled to announce the additional investment by one of our numerous customers’ within our DataExpress™ vertical. This is a testament that the security of data transfers is growing in importance within the payments industry, where they are embracing innovative technologies such as ours that modernize and secure payment and currency transfers of all kinds.”
LandStar, Inc. (LDSR), closed Tuesday's trading session at $0.0008, even for the day, on 1,806,054 volume with 10 trades. The average volume for the last 3 months is 16,447,553 and the stock's 52-week low/high is $0.000399999/$0.0073.
Orezone Gold Corporation (ORZCF)
Gold Stock Data, Investing.com, Investors Hangout, Investing News, Investor Place, Exploration Insights, Macroaxis, TeleTrader, Northern Miner, Stockhouse, Mining.com, Wallet Investor, Wallmine, Capital Cube, Market Screener, Stockwatch, Dividend, Investor, InvestorsHub, and Street Insider reported beforehand on Orezone Gold Corporation (ORZCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Orezone Gold Corporation engages in the acquisition, exploration, and development of precious metal properties. Its flagship property is the Bomboré gold project located in Burkina Faso, West Africa. The Company owns a 90 percent interest in Bomboré, one of the largest undeveloped gold deposits in Burkina Faso. Orezone Gold has its corporate office in Vancouver, British Columbia.
Bomboré hosts a large oxide resource underlain by a larger, open sulphide resource. It will be developed in two stages. Development has started on the project with the first gold pour scheduled for Q2 2021. Bomboré has premier infrastructure with the majority of support facilities in place. This includes camp, offices, and warehouse facilities.
Orezone Gold released an updated Bomboré Sulphide Expansion Feasibility study this year. Highlights include increasing reserves by 686Koz (+60 percent). In addition, highlights include a low AISC of $672 in the first 10 years. Phase 1 construction is well-advanced. Orezone Gold earlier reported the results of its updated Feasibility Study (the 2019 FS), which incorporates a staged Phase II Sulphide Expansion for its Bomboré Gold Project in Burkina Faso.
Orezone Gold has 12 gold mines in production and 2 in construction. The Company has a proven record of accomplishment of project construction and financing, capital markets and M&A (Mergers & Acquisitions). Orezone has simplified the Bomboré gold project and centered on a scale it can finance and build. Bomboré has strong economics. It has an after-tax NPV5% of $361M and IRR (Internal Rate of Return) of 43.8% with a 2.5-year payback.
Last month, Orezone Gold announced it would begin an approximately 2,000 meter drill programme in September 2019 of diamond and reverse circulation drilling at the Maga Hill area. This is to follow-up on higher than average grade gold mineralization that was confirmed by the 2018 drilling at its Bomboré Gold Project.
The estimation is that this programme will cost roughly USD $200,000. It will consist of approximately 1,350 m of diamond drilling (DD) and approximately 600 m of reverse circulation drilling (RC). The design of this programme is to advance the definition of high-grade shallowly-plunging gold mineralization on the hanging wall of the main Maga zone.
Orezone Gold Corporation (ORZCF), closed Tuesday's trading session at $0.5216, off by 0.647619%, on 20,056 volume with 10 trades. The average volume for the last 3 months is 32,683 and the stock's 52-week low/high is $0.294999986/$0.6699.
Resolute Mining Limited (RMGGF)
Mining Capital, Macroaxis, TipRanks, Street Insider, Wallet Investor, Gold Stock Data, TradingView, Investors Hangout, Stockwatch, Stockhouse, and 4-Traders reported previously on Resolute Mining Limited (RMGGF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Resolute Mining Limited is a gold miner with more than 30 years of experience as an explorer, developer, and operator of gold mines in Australia and Africa. These mines have produced greater than 8Moz of gold. Currently, the Company owns three gold mines. These are the Syama Gold Mine in Mali (Syama), the Ravenswood Gold Mine in Australia (Ravenswood), and the Bibiani Gold Mine in Ghana (Bibiani). Resolute Mining is based in Perth, Australia and the Company lists on the OTC Markets.
Syama is a world class, strong, long-life asset. It is capable of producing more than 300,000oz of gold per annum from existing processing infrastructure. At present, Resolute Mining is commissioning the world’s first fully automated underground gold mine at Syama. It will deliver a low cost, large scale operation with a mine life beyond 2032.
The Syama Underground Mine is owned by Société des Mines de Syama S.A. (SOMISY). Resolute Mining has an 80 percent interest in SOMISY and the Government of Mali has a 20 percent interest in SOMISY. Tabakoroni is owned by Société des Mines de Finkolo SA (SOMIFI) of which Resolute currently owns 100 percent through its wholly owned subsidiary, Resolute (Finkolo) Pty Ltd. The Government of Mali is entitled to a 10 percent free carried interest in SOMIFI.
Ravenswood has been a consistent performer and an important part of Resolute Mining’s business for over 10 years. The highly successful Mt. Wright Underground Mine continues to produce as Ravenswood is transitioned back to large scale, low cost, long life open pit mining as part of its Ravenswood Expansion Project. Resolute Mining owns 100 percent of the Ravenswood Gold Mine via its wholly owned subsidiary, Carpentaria Gold Pty Ltd.
Furthermore, Bibiani represents a growth opportunity for Resolute Mining. Bibiani is a potential long life, high margin operation. Bibiani is owned by Mensin Gold Bibiani Limited, a wholly owned subsidiary of Resolute Mining. Resolute Mining currently owns 100 percent of Mensin Gold Bibiani Limited through its wholly owned subsidiary, Resolute (Bibiani) Pty Ltd. The Government of Ghana is entitled to a 10 percent free carried interest in Mensin Gold Bibiani Limited.
At the end of July 2019, Resolute Mining announced that it signed a binding agreement (Implementation Agreement) with Toro Gold Limited. Resolute Mining will acquire all of the shares of Toro Gold. Toro Gold’s flagship asset is the low-cost, high-margin Mako Gold Mine (Mako) located in Senegal.
Last year, Mako produced 156,926 ounces (oz) of gold at an All-In Sustaining Cost (AISC) of US$655/oz. The addition of Mako expands Resolute Mining’s existing portfolio consisting of the Syama Gold Mine, the Bibiani Gold Mine, and the Ravenswood Gold Mine. Mako will expand Resolute Mining’s production base, strengthen operational cashflow, increase revenues, and provides a strong platform for more growth.
Resolute Mining Limited (RMGGF), closed Tuesday's trading session at $0.98, even for the day, on 1,710 volume. The average volume for the last 3 months is 6,376 and the stock's 52-week low/high is $0.670000016/$1.42999994.
Wize Pharma, Inc. (WIZP)
Dividend Investor, Stockwatch, Capital Cube, Cardinal Weekly, Investors Hangout, Insider Mole, Stockopedia, Penny Stock Hub, Stockhouse, InvestorsHub, Wallmine, OTC Markets, Barchart, MarketWatch, and 4-Traders reported earlier on Wize Pharma, Inc. (WIZP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Wize Pharma, Inc. focuses on the treatment of ophthalmic disorders. This includes dry eye syndrome (DES). The OTCQB-listed Company previously went by the name Star Night Technologies Ltd. It changed its corporate name to Wize Pharma, Inc. in July of 2015. A clinical-stage biopharmaceutical enterprise, the Company is headquartered in Hod Hasharon, Israel.
Wize Pharma has in-licensed certain rights to purchase, market, sell, and distribute a formula named LO2A. This is a drug developed for the treatment of DES, and other ophthalmological illnesses, including conjunctivochalasis (CCH) and Sjögren's Syndrome. Currently, LO2A is registered and marketed by its inventor in Germany and Switzerland for the treatment of DES, in Hungary for the treatment of DES and CCH, and in the Netherlands for the treatment of DES and Sjögren's Syndrome.
Wize Pharma is now conducting a Phase II trial of LO2A for patients with CCH and a Phase IV study for LO2A for DES in patients with Sjögren's. The Company announced in March of last year that it enrolled the initial patient in its Phase IV clinical trial in Israel for LO2A in the symptomatic treatment of dry eye syndrome (DES) in patients with Sjögren's syndrome. This randomized, double-masked study is evaluating LO2A versus Alcon's Systane® Ultra UD, an over-the-counter (OTC) lubricant eye drop product used to relieve dry and irritated eyes.
The design of the study (in addition to meeting marketing approval requirements in Israel) is to support Wize Pharma’s clinical approval pathway for LO2A for the treatment of DES in patients with Sjögren's in other markets including the U.S., China, and Ukraine. LO2A is already approved in Israel for the treatment of DES.
This past November, Wize Pharma announced top line results from its Phase II clinical trial in Israel of LO2A for the symptomatic treatment of dry eye syndrome (DES) in patients with moderate to severe conjunctivochalasis (CCh). Wize Pharma's Chairman, Noam Danenberg, stated, "We are very pleased with these top line results and we look forward to analyzing the full results. We believe the full results from this study, will support our clinical development path and provide firm basis for presentation and discussions with the FDA for the approval pathway of LO2A in the U.S. and additional countries."
Recently, Wize Pharma announced that it signed an agreement with Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX) to form a joint venture (JV) company for researching, developing and administering cannabinoid formulations to treat ophthalmic conditions. Cannabics Pharmaceuticals is a global leader in personalized cannabinoid medicine centered on cancer and its side effects.
This agreement will become effective subject to receipt of an expert opinion, within 30 days from the date of signing, describing the regulatory pathway for eye drops containing cannabinoids. Upon effectiveness, Wize Pharma shall issue 900,000 shares of its common stock to Cannabics Pharmaceuticals. Cannabics shall issue 2,263,944 shares of its common stock to Wize. This agreement will expire if the parties have not approved a business plan by June 30, 2019.
Wize Pharma, Inc. (WIZP), closed Tuesday's trading session at $0.22545, up 50.30%, on 6,100 volume with 4 trades. The average volume for the last 3 months is 5,476 and the stock's 52-week low/high is $0.100000001/$2.3900001.
Astea International, Inc. (ATEA)
Stocktwits, Simply Wall St, Zacks, YCharts, last10k, OTC Markets, MarketWatch, InvestorsHub, Stockhouse, Business Insider, and The Street reported previously on Astea International, Inc. (ATEA), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Astea International, Inc. is a worldwide leader in field service and mobile workforce management. The Company’s solutions unify processes, people, parts, and information to center the entire organization on the creation of sustainable value in highly competitive, global markets. Astea provides integrated solutions to assist in maximizing efficiencies, improve revenues, and enhance customer satisfaction. OTCQB-listed, Astea International is based in Horsham, Pennsylvania.
Astea is an international provider of end-to-end service management software solutions. These solutions offer all the foundations of service lifecycle management. These include customer management, depot repair, service management, asset management, warranty management, forward and reverse logistics, and mobile and optimization. The Company has expertise in service management, distribution, logistics, as well as system applications. The main elements of its professional services are impact assessment, consulting services, and training & support. Astea International provides on-premise and cloud delivery models. This allows every company to choose the right one that aligns with their strategy and Information Technology (IT) ecosystem.
Astea, by way its Japanese subsidiary, has partnered with Kobelco Systems Corporation. This is to enable wide-ranging Internet of Things (IoT) and Artificial Intelligence (AI) capabilities on its field service management platform, Astea Alliance™. Kobelco Systems' IoT infrastructure platform and AI analytical service are now totally integrated into the Astea Alliance platform to optimize the maintenance activities of original equipment manufacturers (OEMs), improving overall productivity for assembly lines, plants, and supply chains.
Astea and XOi Technologies have a partnership to expand their combined offerings to field service providers globally through integrating XOi's Vision™ into the Astea Alliance™ field service management and mobility platform. Vision™ is an augmented reality and visual intelligence solution.
Astea International has launched its Alliance Enterprise™. This is the newest version of its award-winning Alliance field service management and mobility platform. Alliance Enterprise introduces to the field service industry a totally new perspective on how an enterprise-grade technology can unify the increasingly complex ecosystem in which service-driven companies must operate.
This past December, Astea International announced that it earned the 2018 Company of the Year Award in Mobile Field Service Management from Frost & Sullivan. Based on its analysis of the field service management software industry, Frost & Sullivan chose Astea International for its comprehensive and user-oriented mobile field service application portfolio, its ability to meet the changing needs of field service organizations, and its visionary partnerships with emerging technology vendors.
Astea International, Inc. (ATEA), closed Tuesday's trading session at $11.45, up 129.4589%, on 765,097 volume with 626 trades. The average volume for the last 3 months is 2,124 and the stock's 52-week low/high is $1.25/$11.6999998.
Esports Entertainment Group, Inc. (GMBL)
Stockrow, Real Pennies, Dividend Investor, Proactive Investors, Capital Network, Infront Analytics, YCharts, OTC Markets, RedChip, Marketbeat, TradingView, Capital Cube, and Wallet Investor reported earlier on Esports Entertainment Group, Inc. (GMBL), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Esports Entertainment Group, Inc. is a next generation, licensed, online gambling business especially focused on esports wagering. Its plan is to offer wagering on esports events in a fully licensed, regulated, and secured platform to the global esports audience, excluding the United States. Esports Entertainment Group has offices in St. Mary's, Antigua, and Barbuda.
Last week, Esports Entertainment Group announced the hiring of two key executives and the opening of its new international headquarters in Malta. Malta was selected because of its strategic location within the European Union (EU), and also access to a highly educated and multi-lingual workforce, particularly in the fields of online gambling.
The Company’s plan is to offer users around the world the ability to participate in multi-player video games tournaments online for cash prizes. At present, the Company is developing several play money websites and its real money wagering website.
Esports Entertainment is a licensed online gambling business with a particular emphasis on esports wagering and 18+ gaming. The Company’s online esports gambling platform will be completely licensed and the highest regulated esports gambling site worldwide.
The Company has been issued a Client Provider Authorization Permit by the Kahnawake Gaming Commission. Esports has applied for an Interactive Wagering License with the Financial Services Regulatory Commission of Antigua and Barbuda to conduct real money interactive gaming on a worldwide basis from centers in Canada and Antigua.
Esports Entertainment has an agreement with PartnerMatrix. This is the first platform that enables online sportsbook and casino operators to run Affiliate System with Agent functionality and Agent System with Affiliate functionality. With the agreement, Esports Entertainment Group will integrate the PartnerMatrix platform to manage its affiliate program on an expedited basis. Esports Entertainment Group has also launched vie.gg. This is the world’s first and most transparent esports betting exchange.
Recently, Esports Entertainment Group announced Affiliate Marketing Agreements with 14 more esports teams as it continues to ramp up affiliate marketing activities in support of its launch of vie.gg. The addition of these 14 esports teams brings the total number of esports team affiliates to 190 since the Company’s first announcement on April 5, 2018.
Esports Entertainment Group, Inc. (GMBL), closed Tuesday's trading session at $0.98, up 27.6873%, on 71,351 volume with 81 trades. The average volume for the last 3 months is 17,440 and the stock's 52-week low/high is $0.263999998/$1.04999995.
Maricann Group, Inc. (MRRCF)
Weed Newswire, OTC Markets, Barchart, NewCannabisVentures, Stockhouse, Investopedia, Insider Financial, YCharts, The Street, MarketWatch, 4-Traders, Marketwired, Investors Hub, and TradingView reported on Maricann Group, Inc. (MRRCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Maricann Group, Inc. produces and distributes marijuana for medical purposes. The Company offers dried marijuana, cannabis oil, and gums. In addition, it provides accessories. These includes vaporizers, grinders, and other paraphernalia. OTCQB-listed, Maricann Group has its head office in Burlington, Ontario, and Munich, Germany. The Company has production facilities in Langton, Ontario.
On September 24, 2018, Maricann Group announced that it intends to change its name to Wayland Group Corp. In the interim, it expects to start operating via its subsidiaries under the business name “Wayland Group”. In expectation of the proposed name change, the Company also announced that, effective September 25, 2018, its ticker symbol on the Canadian Securities Exchange will be “WAYL”.
The Company is a licensed producer of medical cannabis under Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). Maricann Group has federal licenses in Canada to cultivate, extract, formulate, and distribute cannabis.
In Langton, Ontario, Maricann operates a medicinal cannabis cultivation, extraction, and formulation and distribution business under federal license from the Government of Canada, and Dresden, Saxony, Germany. The Company’s new, state-of-the-art, fully dedicated cannabis production facility in Langton is on 100 acres of land. At present, the Company is undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) build out, to support existing and future patient growth.
The Company’s Germany-based Ebersbach facility targets the significant European market with 820,000 sq. ft. of cultivation space and greater than 12,000 patients. Maricann has developed educational programming for patients and healthcare professionals. Through exclusive pharmacy agreements with approximately 20 percent of the nation’s pharmacies, Maricann is working to become a leading provider of cannabis at physical point-of-sale locations that patients trust.
One of Maricann Group’s acquisition’s is NanoLeaf Technologies. NanoLeaf is a biotechnology company. It has licensing rights to a number of globally patented technologies that provide proven pharmaceutical, nutraceutical, cosmetic, and functional beverage drug delivery formulations. Maricann’s Vesisorb is the first standardized dose cannabinoid soft gel capsule with a nano-dispersed carrier for the drug that is ideal for ingestional bioavailability.
Additionally, Maricann Group acquired Haxxon AG. The acquisition of Haxxon forms an important element of Maricann’s European expansion strategy. Maricann is now positioned to enter the Swiss market via Haxxon’s production of feminized high CBD cannabis plants.
Recently, Maricann (Wayland Group) announced that it will open its first retail location in Zurich, Switzerland in 2019. It will serve the market with high-quality cannabis products, which contain a maximum THC content of 1 percent. The opportunity comes on the heels of the Company’s strategic acquisition of Haxxon AG, granting Maricann (Wayland) the opportunity to take advantage of Haxxon’s production facilities in Regensdorf, Switzerland, and its production of feminized high CBD cannabis plants.
Maricann (Wayland Group) also recently announced that it entered into an agreement to supply Cannamedical Pharma GmbH, a licensed, privately owned importer and distributor of cannabis in Germany to more than 2,200 pharmacies, with a minimum of 9,000 kilograms of EU-GMP certified cannabis flowers over a three year term. The two companies have completed mandatory quality assurance and control audits. They have scheduled the first shipment in December of this year.
Maricann Group, Inc. (MRRCF), closed Tuesday's trading session at $0.065, up 20.3704%, on 206,371 volume with 38 trades. The average volume for the last 3 months is 73,013 and the stock's 52-week low/high is $0.0511/$1.50999999.
Goldsource Mines, Inc. (GXSFF)
Stockhouse, Street Insider, Barchart, Mining Stock Valuator, MarketWatch, The Prospector News, 4-Traders, WalletInvestor, Resource World, TipRanks, Marketbeat, Investors Hangout, OTC Markets, The Stock Market Watch, and Geology for Investors reported on Goldsource Mines, Inc. (GXSFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Goldsource Mines, Inc. is a resource enterprise now in the Proof of Concept Phase at its 100 percent-owned Eagle Mountain Gold Project in Guyana, South Africa. The Company’s vision at Eagle Mountain is to support a large-scale open pit gravity/CIL gold operation, centered on low strip ratio, low cost mining of Eagle Mountain’s surficial saprolite resources. Goldsource Mines has its corporate headquarters in Vancouver, British Columbia.
The Eagle Mountain Gold Project is roughly 200 km southwest of Guyana’s capital, Georgetown. It is 45 km from the historic Omai Gold Mine. At Eagle Mountain, Goldsource Mines built in 2015, and operated in 2016, a 1,000 t/d gravity pilot processing plant. A Pre-Feasibility Study (PFS) for a gravity/cyanidation medium size operation is in progress.
Goldsource Mines also has its Border Property in the Province of Saskatchewan. The Border Property is the focus of a major coal discovery in 2008. This property is on the eastern edge of mining-friendly central Saskatchewan, approximately 50 kilometers north of the town of Hudson Bay. The Border Property comprises roughly 16,073 hectares. It is along the Durango Coal Trend that continues to the southeast and northwest of the property.
This past April, Goldsource Mines announced that on March 29, 2018, the Company, via its subsidiary and with its local joint venture partner in Guyana, Kilroy Mining, Inc., executed a definitive agreement with a local Guyanese individual for the option to explore and purchase a 100 percent interest in the Bishop Growler Property.
Bishop Growler is positioned along the projected mineralized trend three kilometers from Goldsource Mines’ Eagle Mountain Gold Project in Guyana, South America. It is surrounded by Eagle Mountain's existing 5,030-hectare Prospecting License (EMPL).
Recently, Goldsource Mines announced positive metallurgical test results on its continuing saprolite expansion program at its Eagle Mountain Gold Project. In addition to ongoing drilling and trenching at Eagle Mountain, Goldsource is progressing on metallurgical test work. This includes grinding cost-benefit analysis studies.
Moreover, in May, Goldsource Mines announced a new discovery and further positive results on its ongoing saprolite exploration program at its Eagle Mountain Gold Project. The new discovery, "Salbora" area, is about 1.5 kilometers northwest of the Eagle Mountain deposit.
Through diamond drilling, Goldsource also received positive results on an earlier announced expansion target, "Friendly" area, situated at the northern edge of the Eagle Mountain deposit. The most significant result for this release was returned from Trench TRSB18-002 at the Salbora Area, which intersected 123 meters (horizontal width) grading 1.92 grams per tonne (gpt) gold.
Goldsource Mines, Inc. (GXSFF), closed Tuesday's trading session at $0.06, up 20.00%, on 111,400 volume with 10 trades. The average volume for the last 3 months is 176,033 and the stock's 52-week low/high is $0.019999999/$0.162699997.
Tempus Applied Solutions Holdings, Inc. (TMPS)
MarketWatch and InvestorsHub reported on Tempus Applied Solutions Holdings, Inc. (TMPS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Tempus Applied Solutions Holdings, Inc. provides design, engineering, systems integration, and flight operations solutions. These support critical aviation mission requirements for a variety of customers. The OTCQB-listed Company maintains a highly qualified and skilled in-house engineering team, which supports aircraft modifications, certification, maintenance, and flight testing.
Tempus Applied Solutions, LLC is the wholly-owned subsidiary of Tempus Applied Solutions Holdings; Inc. Tempus Applied Solutions has its corporate office in Williamsburg, Virginia. The Company uses a secure facility with hangar and manufacturing space and secure communications at Brunswick Executive Airport. The facility has two parallel 8000’ x 200’ runways and a 4.5-million-square-foot ramp and taxiways - certified for B-747, A-340, and and C-5 aircraft.
Tempus has in-house DER (Designated Engineering Representatives) capabilities covering 41 categories of aircraft systems. Capabilities include Part 23 Aircraft and Part 25 Aircraft and also Repair Station DER. In addition, authorities encompass mechanical systems, electrical systems, and flight testing.
The Tempus Design & Engineering Center of Excellence has Designated Engineering Representative (DER) authority from the Federal Aviation Administration (FAA) and the European Aviation Safety Agency (EASA). This center’s specialties include major airframe modifications; interior completions projects; design and materials specifications; modeling and rendering utilizing 3D Max Vision; Supplemental Type Certificates (STC); and Layout of Passenger Accommodations (LOPA) Development.
Tempus flies airplanes - fixed wing and rotary, manned or unmanned. The Company engages in surveillance missions in Africa to flight training in Texas. Also, Tempus designs and modifies aircraft for special missions, certifies them, and provides turnkey lease and service solutions.
Tempus operates Gulfstream, Bombardier, Pilatus, and Cessna aircraft. The majority of these aircraft have been specially modified by the Company for Department of Defense (DoD)-related missions. This includes threat simulation, surveillance, communications relay, and diverse test and development programs.
The Tempus Applied Solutions subsidiary was awarded FAA (Federal Aviation Administration) approval, in the form of a Supplemental Type Certificate (STC), for Tempus' initial FANS/1-A and ADS-B compliance solution [(Tempus' "Solution AA")]. Tempus' solution received an "Approved Model List", or AML, STC. This means that it can be applied to any business and commercial aircraft. FANS and ADS-B compliance will be mandated in most parts of the world by 2020.
Recently, Tempus Applied Solutions announced that it finalized the acquisition of six Lockheed L-1011s previously owned and operated by the Royal Air Force (RAF) of the United Kingdom. Four of these aircraft are specifically configured for air-to-air refueling (AAR) operations. The remaining two are configured for passenger and cargo operations only. The aircraft beforehand served the RAF and NATO.
Tempus Applied Solutions Holdings, Inc. (TMPS), closed Tuesday's trading session at $0.2399, up 19.95%, on 28,430 volume with 8 trades. The average volume for the last 3 months is 60,330 and the stock's 52-week low/high is $0.031099999/$0.735000014.
Provision Holding, Inc. (PVHO)
GrowthPennyStocks, Penny Stock General, Shiznit Stocks, HotStockProfits, PennyDoctor, Stock Beast, RedChip, PennyStockLocks.com, Epic Stock Picks, Equity Observer, Value Penny Stocks, Wolf of Penny Stocks, Small Cap Firm, OTCMagic, MicroCapDaily, and StockRockandRoll reported on Provision Holding, Inc. (PVHO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Provision Holding, Inc., by way of its subsidiary, focuses on the development and distribution of intelligent interactive three-dimensional (3D) holographic display technologies, software, and integrated solutions for consumer and commercial centered application. These are chiefly for advertising and product merchandising markets. The Company’s initial line of display systems has proven to be ideally suited for indoor and outdoor point-of-sale (PoS), merchandising, and PoS related advertising venues. Provision Interactive Technologies, Inc. is a subsidiary of Provision Holding. Provision Holding is based in Chatsworth, California.
Provision’s products include HoloVision displays and 3D Savings Center kiosks. These enable advertisers and customers to reach captive audiences in grocery stores, malls, convenience stores, gas stations, banks, as well as other retail sites. The Company’s proprietary 3D holographic display technologies give advertisers first-rate ability to direct customized content to a target audience.
Provision's 3D holographic display systems represent a unique technology. This technology provides the projection of full color, high-resolution videos into space detached from the screen, without any special glasses. The Company has completed the development and prototype of its latest 3D holographic display system, the HL50.
The HL50 is its largest Holovision™ product. The design of it is for exhibitions and special events. The HL50 uses Provision Interactive Technologies’ patented and award-winning 3D holographic technology. It comes complete. This includes a media player and the Company’s proprietary software, HoloSoft™. The HL50 can project visually stunning 3D holographic videos, detached from the screen, floating in space more than 40 inches outward.
This past June, Provision Interactive Technologies announced that the Company entered into a multi-year partnership agreement with Discount Drug Mart, Inc. This partnership agreement is to install Provision’s proprietary 3D Savings Center kiosks inside Discount Drug Mart stores. The agreement represents the next major retail partnership for Provision.
Prosperity Investments, under its Joyful ATM brand, has entered into an agreement with Provision Interactive Technologies to integrate its 3D holographic display and coupon redemption platform into Joyful ATMs to boost in-store engagement and purchases at point-of-sale (PoS).
Greater than 48,000 Joyful ATM units are planned to undergo deployment across the U.S. and in another 68 countries over the next 72 months, at locations including banks, retailers, convenience stores, gas stations, and government buildings. Via the partnership, the ATMs will project 3D holographic advertising messages to attract customers to the unit. Upon the customer approaching the unit, they can redeem coupons for the advertised products that can be used right away, driving enhanced PoS activity.
Provision Holding, Inc. (PVHO), closed Tuesday's trading session at $0.0042, up 27.2727%, on 100,000 volume with 1 trade. The average volume for the last 3 months is 741,337 and the stock's 52-week low/high is $0.002499999/$0.0302.
The QualityStocks Company Corner
- Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
- Nightfood Holdings, Inc. (OTCQB: NGTF)
- Sharing Services Global Corporation (SHRG)
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
- Predictive Oncology (NASDAQ: POAI)
- B2Digital Inc. (OTC: BTDG)
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- Neutra Corp. (OTCQB: NTRR)
- INmune Bio Inc. (NASDAQ: INMB)
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
- Sugarmade, Inc. (SGMD)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF)
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) on Monday announced termination of the proposed investment into The Physician's Choice CBD ("PCCBD") of Phoenix, Arizona, as previously disclosed in April 2019. To view the full press release, visit http://cnw.fm/jH8b7.
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.
Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.
- Investment and funding for rapid growth
- Vertical integration solutions
- Construction, design and/or optimization of indoor or outdoor cultivation facilities
- Reputation management & influencer outreach
- Branding and Packaging
- Social Media and Media outreach
With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.
Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.
Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.
Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."
Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.
Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).
Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.
Chemistree Technology Inc. (CHMJF), closed Tuesday's trading session at $0.1494, up 0.504541%, on 26,172 volume with 8 trades. The average volume for the last 3 months is 25,475 and the stock's 52-week low/high is $0.094999998/$0.578999996.
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Announces Cancellation of PCCBD Investment
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Voices Support of SAFE Banking Act
- Chemistree Applauds Initial Success for Safe Banking Act in U.S.
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
Lexaria Bioscience Corp. (OTC:LXRP) (CNSX:LXX.CN) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to provide this update on the ongoing relationship and pursuit of innovation in oral, reduced risk nicotine consumer products using Lexaria's patented DehydraTECHTM technology, underway between Altria Ventures Inc., an indirect wholly owned subsidiary of Altria Group, Inc (NYSE:MO) ("Altria") and Lexaria's majority owned subsidiary Lexaria Nicotine LLC ("Lexaria Nicotine"). Also today, the company was featured in a publication from CannabisNewsWire examining how as Canada prepares to roll out its ‘Cannabis 2.0’ wave of product legalization focused on edible and drinkable forms of the plant’s core ingredients less than a month from now, with the products themselves hitting store shelves beginning in December, analysts are anticipating a consumables market rife with opportunity for innovation. Deloitte predicts the Canadian market for edibles and alternative cannabis products alone will be worth $2.7 billion annually, and that cannabis extract-based products including edibles will make up nearly 60 percent of that amount at $1.6 billion (http://cnw.fm/Mh0U0).
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.
Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hmep-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.
Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.
In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.
Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.
Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed Tuesday's trading session at $0.52, up 8.3333%, on 115,400 volume with 84 trades. The average volume for the last 3 months is 85,143 and the stock's 52-week low/high is $0.399800002/$2.00.
- Lexaria Bioscience Provides Update on R&D Program Progress under License Agreement with Altria
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Riding High on Potential Cannabis, Nicotine Uses of Patented Technology
- Global CBD Prices Reduce as US Supply Shakes the Market
Nightfood Holdings, Inc. (OTCQB: NGTF)
Nightfood, Inc. (OTCQB: NGTF), the innovative ice cream company addressing America’s $50 billion-dollar nighttime snacking problem, announced today that sleep-friendly Nightfood ice cream is available in the Harris Teeter supermarket chain. With over 250 locations in North Carolina, South Carolina, Virginia, Georgia, Maryland, Delaware, Florida and the District of Columbia, Harris Teeter is Nightfood’s largest retail partner to date.
Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.
Nightfood Ice Cream
Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.
Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.
With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.
Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.
More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.
Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.
Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.
Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.
Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.
MJ Munchies, Inc.
MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.
Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.
Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.
Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.
CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.
The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.
Nightfood Holdings, Inc. (NGTF), closed Tuesday's trading session at $0.285, up 29.5455%, on 1,267,348 volume with 190 trades. The average volume for the last 3 months is 133,219 and the stock's 52-week low/high is $0.160099998/$0.920000016.
- Nightfood Announces Distribution in Harris Teeter Supermarkets, Adding Over 250 Stores Throughout the Southeast and Mid-Atlantic Regions
- Nightfood Holdings Inc. (NGTF) Reports Record Quarterly Revenues, Data Indicating Steadily Increasing Same Store Sales
- Nightfood Holdings Inc. (NGTF) Products Spotted on Shelves in New Supermarket Chain
Sharing Services Global Corporation (SHRG)
On September 18, more than 125 executives and independent direct sellers gathered on Capitol Hill to represent 19 Direct Selling Association (DSA) member businesses and over six million entrepreneurs. Participants met with members of Congress to support the passage of H.R. 3522 (http://nnw.fm/5mFoB), the Preserving the Direct Seller Independence Act. Together, they emphasized the importance of protecting independent workers and discussed the benefits direct selling has brought to millions of Americans. Participants spoke with nearly 100 Congress members, urging them to maintain the independent contractor status for all direct sellers. Sharing Services Global Corporation (OTCQB: SHRG), a diversified holdings company, is working to elevate these home-based entrepreneurs.
Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.
Sharing Services Inc. subsidiaries include:
- A growing international network of home-based entrepreneurs, called “Elepreneurs”
- Growing selection of health and wellness products dedicated to elevating the well-being of all people
- Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
- Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
- Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
- Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness
Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.
“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”
The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.
Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.
“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”
Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.
The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.
John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.
Sharing Services Global Corporation (SHRG), closed Tuesday's trading session at $0.20, even for the day, on 12,507 volume. The average volume for the last 3 months is 35,801 and the stock's 52-week low/high is $0.090000003/$0.3944.
- Sharing Services Global Corporation (SHRG) Offers Independence, Flexibility and Happiness
- Sharing Services Inc. (SHRG) Focuses on International Expansion
- Sharing Services Global Corporation (SHRG) Strongly Positioned for Global Growth, Success
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) was featured today in a publication from CBDWire, examining how for the past decade or so, CBD has slowly but surely been shedding the stigma that was once associated with it. It’s a lot more mainstream these days, and chances are you know someone who uses CBD, if you don’t use it yourself.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.
Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.
Gathered within the growing family of Wildflower brands are the following entities:
- Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
- King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
- Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.
Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.
Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.
In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.
Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.
William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.
CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.
Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.
Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.
Wildflower Brands Inc. (WLDFF), closed Tuesday's trading session at $0.25, even for the day, on 2,986 volume with 7 trades. The average volume for the last 3 months is 11,443 and the stock's 52-week low/high is $0.221100002/$0.865499973.
- New Study Finds Florida Residents Among the Heaviest of CBD Users
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Becoming a CBD Wellness Product Leader as Plant-Based Health Market Explodes
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Has Established Itself as a True Global Supplier of CBD Products
Predictive Oncology (NASDAQ: POAI)
Predictive Oncology Inc. (NASDAQ: POAI) is harnessing the power of artificial intelligence (AI) and rich information from patients’ own tumors to improve outcomes for cancer patients. Predictive Oncology applies its proprietary smart tumor profiling and AI platform to extensive genomic and biomarker patient datasets in order to predict tumor drug response and improve clinical outcomes for cancer patients.
Predictive Oncology (POAI) is a data and artificial intelligence-driven discovery services company that provides predictive models of tumor drug response to improve patient outcome. Predictive Oncology harnesses the power of artificial intelligence, collaborating with the pharmaceutical, diagnostic and biotech industries to develop highly customizable assessment methods for patients, which can lead to much more effective treatments.
Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.
Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.
In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.
TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable development of patient specific treatment options.
Skyline Medical’s patented, FDA-cleared STREAMWAY System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.
The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.
Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.
Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.
CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.
Predictive Oncology (POAI), closed Tuesday's trading session at $0.47, even for the day, on 55,450 volume with 161 trades. The average volume for the last 3 months is 59,953 and the stock's 52-week low/high is $0.419999986/$0.850000023.
- Predictive Oncology Inc. (NASDAQ: POAI) Continues to Innovate to Improve Outcomes for Cancer Patients
- Predictive Oncology Inc. (POAI) Sells 10 STREAMWAY® Systems to Prominent Teaching Hospital
- Predictive Oncology Inc. Announces Pricing of Public Offering of Up to $3,167,768.50 of Common Stock
B2Digital Inc. (OTC: BTDG)
B2Digital Inc. (OTC: BTDG) (“B2Digital” or the “Company”) today announces that its revolutionary B2 Social Media Network (“B2SN”) surpassed 3.9 million social media connections in fiscal Q2 2019, marking the largest audience on B2SN since B2SN was launched, with 64,543 unique users engaged from July 1 through Sept. 30, 2019.
B2Digital Inc. (OTC: BTDG) is applying its extensive background in entertainment, television, video and technology to become a full-service live event sports company. Capitalizing on its strong management team, industry relationship, and hands-on experience in the industry, B2Digital is developing and acquiring Mixed Martial Arts (MMA) and sports-related companies to build an integrated premier development league initially for the billion-dollar MMA marketplace.
B2Digital’s management team boasts over 30 years of combined global experience developing more than 20 companies within the sports, television, entertainment, digital distribution and banking transaction industries.
Since its restructuring in 2017, the company is now forging ahead with company chairman and CEO Greg P. Bell at the helm. His expertise, relationships and experience bring a background of more than 40,000 successful live events throughout his career. Under his guidance, B2Digital will create and develop the “Development League” champions that will move on to the MMA major leagues from within the B2 Fighting Series.
In preparation, B2Digital has produced and applied the systems and technologies required to support and maintain infrastructural operations of the company, including: social media marketing, event management, digital ticketing sales, digital video distribution, digital marketing, PPV, fighter management, merchandise sales, brand management and financial control systems. The company has also launched its B2 Social Media Network as the digital distribution system for the B2 Fighting Series.
As part of its growth strategy, B2Digital intends to continue to develop and acquire assets that meet its business model with the goal of becoming a premier vertically integrated live event sports company. In 2017, B2Digital started operating B2 Fighting Series, live MMA events; each year, the top fighters are invited to the live annual B2 Fighting Series National Championship.
B2Digital owns all rights for TV, internet, social media, media, merchandising and trademarks and branding for the B2Digital companies. The company has deployed its B2 Social Media Network digital distribution network for the B2 Fighting Series and has developed and deployed the systems and technologies for the operation of social media marketing, event engagement, digital ticketing sales, digital video distribution, digital marketing, PPV, fighter management, merchandise sales, brand management and financial control systems.
Fight Groups (holdings)
- Colosseum Combat
- United Combat League
- Pinnacle Combat
- Bluegrass MMA
B2 Social Media Network (B2SN)
The B2 Social Media Network (B2SN) provides the connection between the B2Digital live events and the consumer audience by:
- Providing social interaction between consumers regarding B2Digital Properties and current relevant topics to the live events audience
- Offering “FTV” free-to-view live and on-demand TV style broadcasts globally of B2 Digital live events
- Promoting upcoming live events
- Selling tickets to B2 live events electronically
- Promoting the fighters, athletes and participants in the B2Digital live events
Chairman and CEO Greg P. Bell
Greg P. Bell is one of the early pioneers and entrepreneurs in entertainment and digital media and has been working in the field for over 30 years. He was involved in the early creation of the technologies and algorithms that allowed analog media to be transformed into digital bits and compressed data streams and created specific business enterprises that capitalized on the creation of digital transmissions at Scientific Atlanta, Compressions Labs, VCON International and Qwest. Bell was one of the initial vice presidents of business development at Qwest Communications where he developed Qwest’s digital media company, Slingshot Networks. He then ran all operations of Slingshot, reporting to the board of directors, which managed and operated three full time studios including the creation of the broadcast studio in Staples Center, TV and news productions, live events at the Staples Center, distribution of a national television show distributed by Warner Brothers TV Distribution, online television productions and web distribution for the NFL, AFL, NBA, NHL, Boxing, Democratic Convention and live music events.
Upon leaving Slingshot in 2000, Bell founded B3 Development Group, a firm specializing in developing emerging market entertainment and media companies. Bell’s B3 Development Group founded B2 Networks in 2001 which quickly became the defacto standard for watching live PPV sporting events online. B2’s proprietary online system broadcasts live professional and collegiate sporting events online to a global audience, broadcasting over 1,000 live games per month. Bell developed and implemented a merger with B2 Networks and the America ONE Television Network where he became CEO of the combined companies. Under Bell’s direction the company, now called ONE Media Corp., launched the new ONE World Sports TV Network in North America on cable and satellite, with a pure digital end-to-end distribution system, along with continuing the company’s growth in the online distribution of sports and entertainment.
After leaving as CEO of ONE Media Corp., he currently sits as chairman of B3 Development Group, which specializes in developing and fast-tracking emerging entertainment, transaction technology and media distribution companies. Bell continues to expand his holdings and currently has business holdings in ONE Media Corp; B3 Development Gaming Group which under contract with Caymanas Park Race Track, owned by the country of Jamaica, developed Jamaica’s first all-digital state of the art pari-mutuel live sports gaming system for mobile devices and currently is operating under the brand CaymanasToGO for the Caribbean Consumers and is licensed for deployment in the USA to USA-based consumers. The B3 Gaming Group mobile device wagering system and technology allows consumers globally to watch and wager on live horse races and sporting events being held in the UK, USA, Canada and the Caribbean; B3 Gaming Services Group, a premier transaction and customer service group that offers management services to the Gaming industry in the Caribbean, B3 Networks, a premier state of the art digital broadcasting company that developed the B3 television satellite replacement technology which allows TV networks to broadcast globally on the public internet instead of satellites in broadcast quality HD & SD television. B3 Networks has deployed, and services, the B3 technology to broadcast high definition TV signals globally to cable head ends, smart phones and internet connected devices for the Jamaica Education Television Network, the Caymanas Race Track and other mobile applications globally.
Bell has worked at the top technology development companies that developed the digital technologies, which are in use today at Scientific Atlanta, Compression Labs, VCON and Qwest. He also has managed and been directly involved with over 55,000 live events in his 30-year career. He has worked with a diverse group of clients in the entertainment, sports and technology communities including the NFL, NBA, NHL, AHL, NLL, ECHL, IFL, USHL, SPHL, NCAA, NAIA, MISL, AFL, AOL, FOX, UFC, NAAFS, Bellator, WEF, the Staples Center, the Orleans Arena, Oscar De La Hoya, Barbra Streisand, and top entertainment venues, acts and actors. His clients and companies have capitalized on Bell’s knowledge of the world of entertainment, live events, sports, digital television and digital online transaction and distribution systems.
B2Digital Inc. (BTDG), closed Tuesday's trading session at $0.0054, off by 8.4746%, on 252,389 volume with 9 trades. The average volume for the last 3 months is 188,551 and the stock's 52-week low/high is $0.0023/$0.039999999.
- B2Digital (OTC: BTDG) B2 Social Media Network Surpasses 3.9M Connections in Q2 2019
- B2Digital Inc.’s (BTDG) B2 Fighting Series Continues with Pinnacle Combat Event, HRMMA CEO Receives Lifetime Achievement Award
- B2Digital Inc. (BTDG) Comes Out Fighting for MMA Champions by Building Development League
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was highlighted today in a publication from Financialnewsmedia.com, examining how industry reports all seem to agree on one thing: The cannabidiol (CBD) revolution will continue to rise. As consumers accept… and even demand more CBD products, the future is projected to continue to rise in years to come. Statista has reported that it expects that U.S. consumer sales of CBD will reach around 1.8 billion U.S. dollars by 2022.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed Tuesday's trading session at $1.25, off by 3.1008%, on 197,312 volume with 257 trades. The average volume for the last 3 months is 367,874 and the stock's 52-week low/high is $0.843599975/$5.20499992.
- All Indications Point to Billion Dollar CBD Markets Should Continue to Skyrocket
- Growth in the Cannabis Industry Coming Through Ambitious Expansion and Big-Name Partnerships
- Green Growth Brands Opens 150th CBD Shop and Provides Progress Update
Neutra Corp. (OTCQB: NTRR)
Neutra Corp. (OTCQB: NTRR) was featured today in a publication from HempWireNews, examining how hemp production regulations in California vary from county to county. Some counties in California are adamantly against hemp production, while others are in the process of allowing the growth of the hemp crop or have already approved the farmers to grow the crop.
Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.
Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.
Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.
- VIVIS – Neutra continues to expand its market presence in the rapidly growing hemp-derived CBD market and recently acquired VIVIS, an emerging retail brand of hemp-based health and nutritional products. VIVIS’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With VIVIS as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
- J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.
- Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
- ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.
Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.
Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.
Neutra Corp. (OTCQB: NTRR), closed Tuesday's trading session at $0.0008, off by 4.7619%, on 25,108,991 volume with 35 trades. The average volume for the last 3 months is 24,549,924 and the stock's 52-week low/high is $0.0006/$0.0898.
- California Cities and Counties Still Divided on Hemp Cultivation
- Neutra Corp. (NTRR) Subsidiary Nearing Market Release of Hemp-Based Sports Cream Expected to be Hit with Amateur and Pro Athletes
- Neutra Corp. (NTRR) Strengthens CBD Retail Market Position with Recent Acquisition
INmune Bio Inc. (NASDAQ: INMB)
INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announced today that RJ Tesi, M.D., Co-Founder and CEO, will present at the 2nd Annual Advances in Immuno-Oncology USA Congress in San Diego taking place on Oct. 8 and Oct. 9. Dr. Tesi and CJ Barnum, Ph.D., Director of Neuroscience, will also present at the World Immunotherapy Congress taking place in Basel, Switzerland from Oct. 15 through 17.
INmune Bio Inc. (NASDAQ: INMB) is a diversified clinical-stage immunology company developing novel therapies that target distinct parts of a patient's innate immune system to fight disease. Drug candidates INKmune™ and INB03 may be used to treat cancer while XPro1595 targets neuroinflammation as a cause of Alzheimer's disease. INmune Bio's product platforms utilize a precision therapy approach to promote the body's innate immune response to treat unsolved problems in medicine.
INmune Bio is the first biotechnology company to close an initial public offering (IPO) in 2019 and commence trading on The Nasdaq Capital Market. The company also received a "Part the Cloud" award from the Alzheimer's Association in 2018 which included a $1 million grant to advance INmune Bio's XPro1595 drug candidate.
INmune Bio's product pipeline targets three segments of concern:
- Alzheimer's disease/dementia claims 5.5 million patients in the United States. INmune Bio views Alzheimer's as an immunologic disease which changes the drug discovery process, changes the way clinical trials are designed, and may provide hope for patients and caregivers.
- Cancer residual disease which is expected to generate more than 1.7 million new cases yearly with an estimated 609,640 fatalities. INMB believe that converting resting Natural Killer ("NK") cells to primed NK cells, which kill cancerous cells on contact, is an important therapeutic strategy to help clear residual disease.
- Resistance to immunotherapy. By preventing the proliferation and function of cells that resist immunotherapy, patients should have a stronger immune response to cancer cells and may respond better to other cancer treatments including immunotherapy and live longer.
INmune Bio Drug Candidates and Clinical Programs
INKmune is a biologic delivery system that primes a patient's resting NK cells to kill cancer. INKmune targets residual disease for patients that have completed initial cancer therapy (surgery, radiation and/or chemotherapy) and have a low burden of disease with a high risk of relapse.
In late 2019, INKmune will start enrolling patients in a phase I/II trial for women with relapsed refractory ovarian cancer. In many patients, cancer relapse after seemingly effective cancer therapy is due to a failure of the patients own NK cells to eliminate minimal residual disease ("MRD").
Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease.
INB03 is a checkpoint inhibitor that targets myeloid derived suppressor cells ("MDSC") which can produce an immunosuppressive shield that prevents a patient's own immune system from attacking the cancer. INmune Bio is currently completing a monotherapy INB03 phase I trial in patients with advanced solid tumors. The INB03 program will transition into a combination therapy clinical program in the summer of 2019 to prepare for a phase II trial in patients resistant to checkpoint inhibitors due to increased MDSC.
Treatment with INB03 should eliminate MDSC in the tumor microenvironment to allow checkpoint inhibitors to be therapeutically effective.
XPro1595 targets the microglial immune cells of the brain that are activated in many Alzheimer's disease patients. These microglial cells are a cause of neuroinflammation that can kill nerve cells and promote synaptic dysfunction – the cause of dementia in Alzheimer's.
The three-month, phase I trial is expected to enroll 18 patients in summer of 2019. It is designed to measure traditional and novel biomarkers of inflammation in patients with mild to moderate Alzheimer's disease who have neuroinflammation. The trial is supported by a $1 million "Part the Cloud" grant from the Alzheimer's Association. Inflammation, especially chronic inflammation, is being recognized as an important part of the pathology of many diseases including cancer and Alzheimer's disease.
Dr. RJ Tesi, M.D., INmune Bio co-founder, CEO and acting chief medical officer, has been a licensed physician since 1982 and a Fellow of the American College of Surgery since 1991. He received his medical degree from Washington University School of Medicine in 1982 and has served many roles in several development-stage biotech companies focused on treatment of neurodegenerative diseases, hematologic malignancies, and other inflammatory diseases.
CFO David J. Moss co-founder, has been with the company since its formation in September 2015. He holds an MBA from Rice University and a bachelor's degree in economics from the University of California, San Diego. Moss has founded, funded and taken public various companies in a variety of industries since 1995.
Mark Lowdell, Ph.D. co-founder, has served as the chief scientific officer and chief manufacturing officer at INmune Bio since the company's formation. He is a professor of cell and tissue therapy at University College London where he has led a translational immunotherapy group since 1994. He has also been a director of cellular therapy at the Royal Free London NHS Foundation Trust. He received his Ph.D. in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.
Christopher J. Barnum is director of neuroscience at INmune Bio. Barnum is a neuroimmunologist with broad expertise across neurodegenerative and psychiatric diseases holding multiple positions in academic and industry. His focus has been on translating inflammatory therapies into clinical treatments for neurologic diseases using a biomarker-directed approach. Barnum's research has been supported by the NIH, the Michael J. Fox Foundation, and the Alzheimer's Association. He received his Ph.D. in neuroscience from Binghamton University.
INmune Bio Inc. (OTC: INMB), closed Tuesday's trading session at $4.7001, off by 6.5586%, on 24,288 volume with 123 trades. The average volume for the last 3 months is 28,361 and the stock's 52-week low/high is $4.40000009/$11.50.
- INmune Bio Inc. to Present at Advances in Immuno-Oncology USA Congress and at World Immunotherapy Congress in October
- INmune Bio, Inc. (NASDAQ: INMB) CEO Discusses Company Achievements in Interview; Director of Neuroscience to Present at World Immunotherapy Congress
- INmune Bio to Present XPro1595 for Treating Neuroinflammation in Alzheimer’s Disease at 2019 Alzheimer’s Association International Conference (AAIC) Satellite Symposium
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was featured today in a publication from Financialnewsmedia.com, examining how investors would be hard-pressed to find an industry expected to nearly double in value over the next four years. The Brightfield Group says CBD could grow to into a $23.7 billion a year industry in the U.S. by 2023 – a CAGR of 100%. Also today, the company was highlighted in a publication from InvestorBrandNetwork which looks at how, because of its fertile soil and climatic conditions that allow the state to have year-round cultivation, California is predicted to be the future capital of hemp production. However, making it the responsibility of the agricultural commissioner at the county level to pass hemp cultivation ordinances in each of the 58 counties has resulted in other states in the U.S surpassing California in legalizing hemp production. However, in April, the Department of Agriculture in California gave the go-ahead for the hemp growers to be issued with licenses.
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Tuesday's trading session at $3.15, off by 2.1739%, on 1,705,361 volume with 4,457 trades. The average volume for the last 3 months is 1,193,735 and the stock's 52-week low/high is $2.97000002/$8.43999958.
- These are the Biggest Catalysts for CBD in 2020
- California Cities and Counties Still Divided on Hemp Cultivation
- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Representative Assumes Board Positions with Organizations Fostering International Cannabis Industry Growth
Sugarmade, Inc. (SGMD)
Sugarmade, Inc. (SGMD) was featured today in the 420 with CNW by CannabisNewsWire. In the United States today, there are a total of 33 states that have legalized the use marijuana in a medical setting, and 11 states have given the go-ahead to use marijuana for recreational purposes. However, the physician assistant school has not included the education on the effects of cannabis, the natural cannabis-like molecules (endocannabinoids), and the way THC interacts with other medicines as part of their nursing syllabus.
Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6
Sugarmade, Inc. (SGMD), closed Tuesday's trading session at $0.012, off by 4.00%, on 1,577,937 volume with 60 trades. The average volume for the last 3 months is 4,588,963 and the stock's 52-week low/high is $0.00975/$0.164000004.
- 420 with CNW – 5 Things to Discuss about Medical Marijuana with Your Doctor
- CBD Isn’t the Fabled Elixir of Youth, But It’s a Lot Closer Than You’d Think
- 420 with CNW – Medical Marijuana Prices in Michigan Rise as Recreational Sales Near
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that its premium wellness brand and a multi-licensed processor and distributor, Blissco Cannabis Corp., has received Health Canada licensing approval for the sale of cannabis oils from its facility in Langley, British Columbia. To view the full press release, visit http://cnw.fm/FkgG0.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Tuesday's trading session at $0.8112, off by 1.1937%, on 302,837 volume with 291 trades. The average volume for the last 3 months is 466,438 and the stock's 52-week low/high is $0.75/$1.7888.
- Supreme Cannabis Company Inc.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Blissco Wellness Brand Receives Cannabis Oil Sales License
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Posts Record Quarter-End, Year-End Numbers
- Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Providing Premium Brands, Products to Cannabis Industry
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) was featured today by TMX Group, in the View from the C-Suite broadcast regarding how the company’s unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. The View from the C-Suite video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. Videos provide insight into how company executives think in the current business environment. To see the latest View from the C-Suite videos visit www.tmxmoney.com/en/news/csuite.html)
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.
Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.
Canopy Rivers’ expanding portfolio includes:
- Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
- CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
- Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
- James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
- LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
- PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
- Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
- Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
- Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
- TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
- Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.
As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.
Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.
Canopy Rivers Inc. (CNPOF), closed Tuesday's trading session at $1.50, off by 1.7167%, on 209,211 volume with 372 trades. The average volume for the last 3 months is 125,823 and the stock's 52-week low/high is $1.44807004/$5.30999994.
- View from the C-Suite: Narbé Alexandrian, President & Chief Executive Officer, Canopy Rivers Inc., tells his company's story. Filmed on September 24, 2019
- Canopy Rivers Portfolio Company Announces Significant Increase in Health Canada Licensed Infrastructure
- 420 with CNW – Another Marijuana Legalization Bill Introduced in Mexico Legislature
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) B2 Fighting Series Continues with Pinnacle Combat Event, HRMMA CEO Receives Lifetime Achievement Award
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Opens Learning Center Featuring Augmented Reality Games, Educational Content
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) 420 with CNW – FBI Data Shows Cannabis Arrests Increased Last Year
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Portfolio Company Announces Significant Increase in Health Canada Licensed Infrastructure
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Voices Support of SAFE Banking Act
- ChineseInvestors.com (CIIX) Positioned as First Company to Market CBD Products to Chinese-Speaking Consumers
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Names New CFO; Announces Private Placement, Equity Issuances
- CloudCommerce (OTCQB: CLWD) Positioned as Premier Solution Provider for Business Marketing Sector
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Earth Science Tech, Inc. (ETST) Hygee Home Kit Playing Key Role in Fight Against STIs and Undiagnosed Cases
- Endonovo Therapeutics (OTCQB: ENDV) Appoints Recognized Medical Professional and Business Visionary Dr. William Li as Strategic Advisor to the CEO
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Strategic Agreement with Leading Chinese Infrared Camera Manufacturer
- Genprex, Inc. (NASDAQ: GNPX) Pioneering Use of Non-Viral Delivery for Gene Therapy is Gaining Industry Support
- Geyser Brands Inc. (TSX.V: GYSR) University of Wyoming Releases Hemp Publication
- GP Solutions (GWPD) Trading to Recommence October 17, 2019
- Grapefruit Boulevard Investments Inc. (IGNG) 420 with CNW – Cannabis Expo in West Michigan Set to Educate Consumers and Businesses about the Marijuana Industry
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Growth in the Cannabis Industry Coming Through Ambitious Expansion and Big-Name Partnerships
- Green Hygienics Holdings Inc. (GRYN) University of Wyoming Releases Hemp Publication
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- HTC Extraction Systems (TSX.V: HTC) Market Data Hints at Excellent Opportunities for Hemp Biomass Companies Like HTC Extraction Systems
- INmune Bio, Inc. (NASDAQ: INMB) CEO Discusses Company Achievements in Interview; Director of Neuroscience to Present at World Immunotherapy Congress
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Addresses Concerns about Vape Safety, Calls for Stricter Regulation of Black Market
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Global CBD Prices Reduce as US Supply Shakes the Market
- Marijuana Company of America Inc. (MCOA) Global CBD Prices Reduce as US Supply Shakes the Market
- MustGrow Biologics Corp (CSE: MGRO) Outlines Portfolio of Natural Bio-Pesticides and Bio-Fertility Products
- Neutra Corp. (OTCQB: NTRR) Subsidiary Nearing Market Release of Hemp-Based Sports Cream Expected to be Hit with Amateur and Pro Athletes
- Nightfood, Inc. (OTCQB: NGTF) Reports Record Quarterly Revenues, Data Indicating Steadily Increasing Same Store Sales
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Representative Assumes Board Positions with Organizations Fostering International Cannabis Industry Growth
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Ongoing Drill Results Confirm Significant, Near Surface Cobalt and Nickel Mineralization
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Resumes Clean Oil Recovery Technology (CORT) Extraction Following Facility Upgrades
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Announces Launch of Edibles Products into Nevada Adult-Use Cannabis Market
- Predictive Oncology Inc. (NASDAQ: POAI) Sells 10 STREAMWAY® Systems to Prominent Teaching Hospital
- Pressure BioSciences Inc. (PBIO) Zacks Small Cap Research Initiates Coverage on Pressure BioSciences, Inc.
- Quest Patent Research Corp. (QPRC) Holds Broad Portfolio of Intellectual Property Assets
- Sharing Services Global Corporation (SHRG) Focuses on International Expansion
- SinglePoint, Inc. (SING) Australian Trial Shows CBD Gel Reduces Seizures in Epileptic Kids
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Leading Taxi Technology Distributor Increases Purchase Order to Over $850,000
- Spectrum Global Solutions, Inc. (SGSI) Secures $3.3 Million in New Contract Awards
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Announces Expansion With New Manufacturing Facility
- SRAX Inc. (NASDAQ: SRAX) Showcases Company Presentation at Leading Consumer & Media Conference, Reviews Impressive Growth
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) CEO to Participate at September 17 Battery Next Summit in Boulder, CO
- Sugarmade, Inc. (SGMD) CBD Isn’t the Fabled Elixir of Youth, But It’s a Lot Closer Than You’d Think
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Posts Record Quarter-End, Year-End Numbers
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) 420 with CNW – Another Marijuana Legalization Bill Introduced in Mexico Legislature
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Australian Trial Shows CBD Gel Reduces Seizures in Epileptic Kids
- Trxade Group Inc. (TRXD) Empowers Small, Independent Pharmacies
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Reaffirms Timing of First Harvest at Kimmetts and Additional 2020 Cultivation Plans
- VPR Brands, LP (VPRB) Offers Robust Suite of Products in Nicotine, CBD Verticals
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Becoming a CBD Wellness Product Leader as Plant-Based Health Market Explodes
- Willow Biosciences Inc. (CSE: WLLW) London Event Discusses CBD Regulation and Safety
- Xalles Holdings Inc. (XALL) Building Fintech Support Strategy Through Acquisitions, Mentoring
- Youngevity International, Inc. (NASDAQ: YGYI) Announces Dividend Payment Timing for September 2019 Series “D” Cumulative Redeemable Perpetual Preferred Stock
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.